US Pre-Market SEC Filings Roundup — February 02, 2026

03-02-2026

Broadridge Financial Solutions, Inc. filed an 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, margins, or other quantitative metrics disclosed in the provided filing information. No positive or negative performance indicators, guidance changes, or period-over-period comparisons are mentioned.

03-02-2026

Replimune Group, Inc. filed a Form 8-K on 2026-02-03 reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This is a multi-item filing, but specific details on the agreement, financial results, obligation terms, dollar values, or performance metrics are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or directional indicators are provided.

• ·Multi-item 8-K filing (Items 1.01, 2.02, 2.03, 9.01)
• ·Event date: 2026-02-03
• ·Filing AccNo: 0001104659-26-009510, Size: 262 KB
• ·Sector: NOT_DISCLOSED

03-02-2026

Mesa Laboratories Inc. (/CO/) filed a Form 8-K on February 3, 2026 (AccNo: 0000724004-26-000015, Size: 383 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance data.

03-02-2026

Gartner Inc filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or operational details are available, preventing assessment of positive, negative, or flat performance.

03-02-2026

Pentair plc filed an 8-K on February 3, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure with attached financial exhibits.

03-02-2026

Willis Towers Watson PLC filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This is a multi-item filing announcing financial results without quantified data.

• ·Filing Accession Number: 0001171843-26-000577
• ·File Size: 7 MB

03-02-2026

NXP Semiconductors N.V. filed an 8-K on 2026-02-03 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are mentioned.

03-02-2026

Archer-Daniels-Midland Co filed an 8-K on February 3, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were detailed in the provided filing information. No positive or negative performance indicators, guidance, or operational details were disclosed.

03-02-2026

Lithium Americas Corp. filed an 8-K on 2026-02-03 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 referencing Financial Statements and Exhibits. No specific details on the agreement, equity sales, transaction value, parties, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing representing a material event by definition under SEC rules.

03-02-2026

BLACKBOXSTOCKS INC. filed an 8-K on 2026-02-03 reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific proposals, vote results, numerical data, or outcomes are disclosed in the provided filing information. This represents a single-item informational disclosure with no financial or operational metrics mentioned.

03-02-2026

Beasley Broadcast Group Inc filed an 8-K on February 3, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, quantitative data, or scheduled events are explicitly stated in the filing information provided. This appears to be a single-item voluntary disclosure.

03-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are provided in the filing summary. Critical information such as dollar values, percentages, or strategic context is NOT_DISCLOSED.

03-02-2026

Xsolla SPAC 1 filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. This is a multi-item filing with no quantitative metrics, transaction details, or directional financial impacts provided.

03-02-2026

Teradyne, Inc. filed a Form 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.

03-02-2026

The company filed an 8-K on 2026-02-03 (AccNo: 0001213900-26-011029) disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. This filing is categorized as a Merger/Acquisition event. No specific details on parties, deal structure, valuation, terms, metrics, or performance comparisons are disclosed.

03-02-2026

Sable Offshore Corp. filed a Form 8-K on 2026-02-03 disclosing multiple items including Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the agreement or events are provided in the filing summary. No positive or negative performance indicators are mentioned.

03-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons were disclosed. The filing provides structural updates typical of a SPAC-related merger process but lacks specifics on valuation or strategic rationale.

• ·AccNo: 0001213900-26-010970
• ·File Size: 1 MB
• ·Sector: not specified

03-02-2026

THUNDER MOUNTAIN GOLD INC filed an 8-K on 2026-02-03 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, shareholder vote matters or outcomes, fiscal year changes, or contents of exhibits are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.

03-02-2026

Nexstar Media Group, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative developments mentioned.

03-02-2026

GOLD RESOURCE CORP filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the summary. No quantitative data, performance metrics, or directional impacts are disclosed.

03-02-2026

CorVel Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.

03-02-2026

Atkore Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004737), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are disclosed.

03-02-2026

Ellington Financial Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a multi-item voluntary filing with no quantitative data available.

03-02-2026

Enterprise Products Partners L.P. filed a Form 8-K on February 3, 2026 (AccNo: 0001061219-26-000002), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of financial results typical for earnings announcements, with attached exhibits likely containing detailed statements. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

03-02-2026

Bank of Hawaii Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Filing AccNo: 0000046195-26-000007
• ·Filing size: 324 KB

03-02-2026

News Corp filed an 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The specific details of the 'Other Event' and the contents of any financial statements or exhibits are NOT_DISCLOSED in the filing summary. No quantitative metrics, positive or negative developments, or directional impacts are provided.

03-02-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item filing indicating a significant corporate transaction, likely involving financing or debt. No specific transaction value, terms, financial metrics, positive or negative impacts, or other quantitative details are disclosed.

• ·Accession Number: 0001628280-26-004738
• ·File Size: 2 MB

03-02-2026

PepsiCo Inc filed an 8-K on February 3, 2026 (AccNo: 0000077476-26-000009), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified metrics.

03-02-2026

Massimo Group filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, financial statements, exhibits, transaction values, or performance metrics are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative impacts.

03-02-2026

Rithm Capital Corp. filed a Form 8-K on February 03, 2026 (AccNo: 0001556593-26-000007, Size: 730 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a multi-item, voluntary earnings announcement filing with no directional financial metrics available.

03-02-2026

Ingredion Inc filed a Form 8-K on February 03, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. No period-over-period comparisons, guidance, or other quantitative impacts are mentioned.

03-02-2026

Capri Holdings Ltd filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

03-02-2026

SemiLEDs Corp filed a Form 8-K on 2026-02-03 (AccNo: 0001193125-26-034388, Size: 157 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed in the provided information.

• ·AccNo: 0001193125-26-034388
• ·Filing date: 2026-02-03

03-02-2026

ARKO Corp. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were mentioned. No positive, negative, or flat performance metrics were detailed in the provided filing information.

03-02-2026

Merck & Co., Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009495), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing announces financial results but provides no specific quantitative metrics, period-over-period changes, guidance, or other detailed financial data in the available summary. No positive or negative performance indicators are mentioned.

03-02-2026

Marathon Petroleum Corp filed a Form 8-K on February 3, 2026 (AccNo: 0001510295-26-000003, size: 745 KB), reporting under Item 2.02 for Results of Operations and Financial Condition, with Item 9.01 for Financial Statements and Exhibits. No revenue, earnings, guidance, balance sheet impacts, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without specific performance details.

• ·AccNo: 0001510295-26-000003

03-02-2026

RPC Inc filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009496), under Item 2.02 announcing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results release. No specific revenue, earnings, margins, comparisons, guidance, or other metrics are disclosed in the provided filing information.

03-02-2026

Nano Dimension Ltd. filed an 8-K on February 3, 2026, reporting multiple items including entry into a material definitive agreement under Item 1.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. While the material agreement could indicate strategic developments, the delisting notice raises significant compliance concerns. No specific transaction details, financial metrics, dollar values, or impacts are disclosed.

03-02-2026

MPLX LP filed an 8-K on February 3, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

03-02-2026

MARZETTI CO filed a Form 8-K on February 3, 2026 (AccNo: 0000057515-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, but no specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance details are disclosed, rendering the announcement purely structural.

03-02-2026

Utz Brands, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific quantitative metrics such as revenue, earnings, or period-over-period changes are mentioned in the provided summary. No positive, negative, or flat performance indicators are disclosed.

03-02-2026

FuboTV Inc. filed a Form 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item earnings-related filing with no specific revenue, earnings, guidance, or quantitative metrics provided in the summary. No positive or negative performance indicators are disclosed.

03-02-2026

BICYCLE THERAPEUTICS PLC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or financial impacts are provided. No quantitative metrics, performance data, or scheduled events are mentioned.

• ·AccNo: 0001104659-26-009501
• ·File size: 256 KB
• ·Sector: not specified

03-02-2026

PayPal Holdings, Inc. filed an 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item filing likely related to an earnings release, but lacks detailed financial data for further analysis.

03-02-2026

PJT Partners Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034409), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing announces financial results but provides no specific revenue, earnings, guidance, or other metrics in the summary available. No positive or negative performance indicators, period-over-period changes, or strategic details are explicitly stated.

03-02-2026

OneWater Marine Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely containing a voluntary disclosure of material information via attached exhibits, such as a press release. No specific core events, financial metrics, transactions, or quantitative details are disclosed in the filing summary.

03-02-2026

Voyager Acquisition Corp., a Cayman Islands entity, filed an 8-K on 2026-02-03 (AccNo: 0001829126-26-000900, Size: 749 KB) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event, with Item 9.01 providing financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing information. Sector is not specified.

03-02-2026

Spire Inc filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no details on performance variations.

• ·Filing Accession Number: 0001193125-26-034418
• ·Filing Size: 1 MB
• ·Sector: NOT_DISCLOSED

03-02-2026

Eaton Corp plc filed a Form 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or transaction details were disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative data available.

03-02-2026

Galaxy Digital Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are explicitly stated in the filing description. This is an informational earnings-related disclosure without detailed performance indicators.

03-02-2026

Pfizer Inc filed a Form 8-K on 2026-02-03 under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.

03-02-2026

BellRing Brands, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004789), disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial metrics, reasons, or performance are disclosed.

03-02-2026

Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 03, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. Additional details on transactions, guidance, or impacts are NOT_DISCLOSED.

03-02-2026

J&J Snack Foods Corp filed an 8-K on February 3, 2026 (AccNo: 0001437749-26-002719), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits, but lacks quantitative details for deeper analysis.

03-02-2026

Marwynn Holdings, Inc. filed an 8-K on 2026-02-03 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or other quantitative details are disclosed in the provided filing information. This represents a material negative development with no offsetting positive factors mentioned.

03-02-2026

Hamilton Lane INC filed a Form 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were detailed in the provided filing summary. This appears to be a standard earnings-related disclosure without directional performance indicators.

03-02-2026

Relay Therapeutics, Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or impacts provided in the filing summary. No quantitative data, guidance changes, or scheduled events are disclosed.

03-02-2026

Soluna Holdings, Inc. filed a Form 8-K on 2026-02-03 (AccNo: 0001493152-26-004831, size: 273 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information to comply with Regulation FD, with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the summary. No positive or negative metrics are mentioned.

• ·Accession Number: 0001493152-26-004831
• ·Sector: not specified

03-02-2026

Magnera Corp filed an 8-K on February 3, 2026 (AccNo: 0000041719-26-000004), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector information is not specified.

03-02-2026

ATI Inc filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004793), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results with no detailed performance data available.

03-02-2026

Venus Concept Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. This is a multi-item, mandatory filing with no specific details on the agreement's parties, terms, value, strategic rationale, or financial impacts explicitly stated. No quantitative metrics, period-over-period comparisons, or forward-looking guidance were mentioned.

03-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01, alongside unregistered sales of equity securities under Item 3.02. The filing also covers changes in directors or certain officers including compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, deal values, parties, or performance comparisons (positive, negative, or flat) were disclosed.

03-02-2026

TransDigm Group INC filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing details. This is a multi-item, mandatory disclosure typical for earnings announcements.

03-02-2026

Madison Square Garden Entertainment Corp. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004796), under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided information. No period-over-period comparisons, guidance changes, or balanced positive/negative performance details are available.

03-02-2026

Cipher Mining Inc. filed an 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events were disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data available.

03-02-2026

Agassi Sports Entertainment Corp. filed an 8-K on 2026-02-03 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

03-02-2026

Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes, including departures, elections, appointments, and compensatory arrangements under Item 5.02. The filing also includes other events under Item 8.01 and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.

03-02-2026

Jerash Holdings (US), Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure, indicating voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

03-02-2026

W.W. Grainger, Inc. filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

03-02-2026

BALL Corp filed an 8-K on 2026-02-03 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are mentioned in the filing details provided. This is a standard earnings-related disclosure with no quantified positive or negative impacts disclosed.

03-02-2026

HANMI FINANCIAL CORP filed an 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 10 MB. This is a multi-item filing likely including attached exhibits such as a press release or presentation, but no specific details on the disclosed information, financial metrics, transactions, or events are provided. No quantitative data, positive or negative metrics, or material impacts are mentioned.

03-02-2026

Hubbell Inc filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

03-02-2026

Liberty Global Ltd. filed an 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure, indicating dissemination of material non-public information, and Item 9.01 Financial Statements and Exhibits, likely attaching related documents. No specific details on the core event, financial metrics, transactions, or performance changes are disclosed in the filing metadata.

03-02-2026

Powerfleet, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

03-02-2026

ACM Research, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary.

03-02-2026

BioCardia, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. No quantitative data, positive or negative developments, or scheduled events are mentioned.

03-02-2026

Trinity Capital Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034463), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.

03-02-2026

Nukkleus Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or the contents of any exhibits are disclosed in the provided filing information. This is an informational filing with no quantified financial metrics, changes, or directional impacts mentioned.

03-02-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034474), reporting solely under Item 8.01 Other Events. No core event details, financial metrics, transaction values, period-over-period comparisons, positive or negative changes, or other quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure of a material event not covered by other specific 8-K items.

03-02-2026

GRAPHIC PACKAGING HOLDING CO filed an 8-K on 2026-02-03 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, positive or negative metrics, or other quantitative financial data are explicitly stated in the provided filing details.

03-02-2026

CLARIVATE PLC filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the filing summary. No positive, negative, or flat metrics are mentioned.

03-02-2026

Aptevo Therapeutics Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-034473), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, quantitative data, or performance metrics are disclosed.

03-02-2026

SharpLink Gaming, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, under Item 7.01 a Regulation FD Disclosure, and under Item 9.01 financial statements and exhibits. Specific details regarding the nature of the amendments, disclosures, or exhibits are NOT_DISCLOSED. This is a multi-item informational filing with no quantified financial metrics or directional impacts provided.

03-02-2026

Ovintiv Inc. filed an 8-K on 2026-02-03 reporting the completion of an acquisition or disposition of assets under Item 2.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure in Item 7.01 and financial statements and exhibits in Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.

03-02-2026

Walt Disney Co filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; Item 8.01 other events; and Item 9.01 financial statements and exhibits. No specific details on the officer affected, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or scheduled events mentioned.

03-02-2026

Beeline Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001493152-26-004838, Size: 233 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or performance details (positive, negative, or flat) are disclosed in the filing summary. This appears to be a voluntary informational disclosure with attached exhibits.

03-02-2026

Amprius Technologies, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.02 the termination of a material definitive agreement. No additional details on the agreement's nature, parties involved, dollar value, strategic role, or financial impacts were disclosed. This event represents a material negative development by definition, with no offsetting positive metrics mentioned.

03-02-2026

Empery Digital Inc. filed a Form 8-K on February 3, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, positive or negative changes, or quantitative impacts are disclosed in the provided filing information. This multi-item filing indicates significant corporate governance and contractual developments, but lacks content to assess directionality.